lyratherapeutics.com - LYRA Company profit before taxes, interest and amortization

Graphic logo of Lyra Therapeutics (LYRA)

The competitive advantage of Lyra Therapeutics, Inc. (LYRA) requires a portfolio update following the failure of its primary sinusitis drug, although the implant patent base remains strong. Long-term revenue is based on polymer drug delivery systems for ENT patients. Current stability is tied to clinical trial outcomes. The absolute EBITDA level demonstrates real cash flow, with the metric currently standing at 0.00.

LYRA - Lyra Therapeutics Operating profit EBITDA over the range 11/23/2025 - 03/28/2026

Summary analytical data breakdowns for Lyra Therapeutics, Inc (LYRA)

- market value and analyst target forecast:
Fundamental company valuation:Lyra Therapeutics, Inc.
Brand item of Lyra Therapeutics Inc.

This indicator measures the daily operating cash flow before interest and taxes, reflecting the efficiency of the current business model. For Lyra Therapeutics, Inc. (LYRA), the scaling potential of drug delivery patents must translate into profit growth; therefore, stagnation in aggregated EBITDA signals a risk of capital freeze and a lack of expansion in the global market.

Competitors of Lyra Therapeutics, Inc. (LYRA)

Company profit before taxes, interest and amortization HLN (Haleon plc)|KVUE: Operating profit before deduction of amortization|Verona Pharma - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharma - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals, Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization perrigo.com PRGO|Profit before payment of interest, taxes and amortization Alvotech SA (ALVO)|LQDA (Liquidia Corp) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA GLPG (Galapagos N.V.)|Operating profit EBITDA ANI Pharmaceuticals Corp ANIP|Afrezza - Operating profit EBITDA|amphastar.com (AMPH) - Operating profit before deduction of amortization|PCRX: Operating profit EBITDA|SPRY - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Theravance|Profit before interest, taxes and amortization Aquestive Corp AQST|Operating profit EBITDA SCPH|TECX - Profit before interest, taxes and amortization|Tonix Pharmaceuticals Holding Corp. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization SXTC|Eupraxia Pharmaceuticals, Inc. - Operating profit EBITDA|BHST: Profit before payment of interest, taxes and amortization|invizyne.com (EXOZ) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ORMP (Oramed)|ENTX (Entera Bio) - Operating profit EBITDA|HYFT: Income before deduction of interest, taxes and amortization|Operating profit EBITDA ABVC|Cumberland Pharmaceuticals - Operating profit before amortization|Profit before payment of interest, taxes and amortization Quantum BioPharma Ltd. QNTM|FGEN: Operating profit before amortization|TELO - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Rani Therapeutics Holdings|SNYR: Operating profit EBITDA|Profit before deduction of interest, taxes, depreciation and amortization RLYB (Rallybio Corp.)|LEXX (Lexaria Bioscience Corp.) - Operating profit EBITDA|pulmatrix.com (PULM) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Pheton (PTHL)|Operating income before deduction of amortization Aptorum Group Ltd|Profit before payment of interest, taxes and amortization Impact BioMedical Inc IBO|TNFA - Operating profit before deduction of amortization|cbdMD, Inc. - Operating profit EBITDA|Income before deduction of interest, taxes and amortization PRFX (PainReform Ltd.)|CYTO (altamiratherapeutics.com) - Operating profit before deduction of amortization|LIPO: Company profit before taxes, interest and amortization|OPTN (Optinose) - Operating profit EBITDA|Operating profit before deduction of amortization Pieris (PIRS)|Profit before payment of interest, taxes and amortization Procaps Group S.A. (PROC)|Operating profit EBITDA petrospharma.com (PTPI)|Profit before payment of interest, taxes and amortization Qilian International Holding QLI|Income before deduction of interest, taxes and amortization SLRN|TFF Pharmaceuticals, Inc. - Operating profit EBITDA